[Nizoral. The outlook for its use and side effects].
Potekaev
N S
NS
Shuginina
E A
EA
D000818:Animals; D001424:Bacterial Infections / Q000188:drug therapy; D003881:Dermatomycoses / Q000188:drug therapy; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D006090:Gram-Negative Bacteria; D006801:Humans; D007654:Ketoconazole / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008099:Liver / Q000187:drug effects
D007654:Ketoconazole
Nizoral. Perspektivy primeneniia i pobochnoe deistvie.